New Plant-Based beverage aims to keep seniors healthier longer
NCT ID NCT07409480
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a specially designed plant-based drink for adults aged 60 to 80. The drink contains vitamin D, zinc, and other nutrients meant to strengthen the immune system and reduce inflammation. Researchers will compare it to a plain plant-based drink over several weeks to see if it improves markers of health and nutrition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Functional plant-based beverage with vitamin D, zinc, FOS, and L-leucine
What this could lead to
If it works, this could point toward a simple dietary supplement that helps older adults maintain better immune function and reduce inflammation, supporting healthier aging.
What could go wrong
This is a small, early-stage trial with only 70 participants, so results may not apply broadly. The beverage is a dietary supplement, not a drug, so any benefits are likely modest and may not be clinically significant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universitat Rovira i Virgili
Reus, Tarragona, 43201, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••